Expert Review of Anti-Infective Therapy

Papers
(The TQCC of Expert Review of Anti-Infective Therapy is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials205
Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review88
Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and a71
Neonatal ocular prophylaxis in the United States: is it still necessary?62
Antiviral drugs for coronavirus disease 2019 (COVID-19): a systematic review with network meta-analysis61
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin60
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies60
Challenges in preserving antibiotic effectiveness: time for a novel approach49
Visceral leishmaniasis elimination in India: progress and the road ahead46
Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complex42
The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis41
NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects39
A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future38
Preventing healthcare-related infections among older adults: a focus on cross-transmission of antibiotic-resistant bacteria37
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines36
Nontuberculous mycobacterial pulmonary disease and the potential role of SPR72036
The emergence of Japanese encephalitis as a public health concern in New South Wales Australia35
Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies34
Tineas caused by hedgehogs due to Trichophyton erinacei an ascending agent of dermatophytosis33
New and emerging roles for inhalational and direct antifungal drug delivery approaches for treatment of invasive fungal infections33
Hypoalbuminemia as a predictor of severe dengue: a systematic review and meta-analysis31
IL28B, TLR7 SNPs, and cytomegalovirus infection are risk factors for advanced liver disease in chronic hepatitis C patients30
Response to: ‘letter to the editor: “A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials “’29
Accuracy of gradient diffusion method for susceptibility testing of dalbavancin and comparators29
Decoding drug resistance in Mycobacterium tuberculosis complex: genetic insights and future challenges27
Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China26
Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials25
The rationale for including osteopathic manipulative treatment in the management of infections: a hermeneutic review24
All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies23
Treatment of vaginitis caused by non-albicans Candida species22
Reemergence of monkeypox: prevention and management21
Iatrogenic factors of Helicobacter pylori eradication failure: lessons from the frontline21
The ongoing challenge of prevention of pertussis in infants: what’s new in 2024?20
The antifungal activity of caspofungin in combination with antifungals or non-antifungals against Candida species in vitro and in clinical therapy20
Direct or early Discharge of Acute Bacterial Skin and Skin Structure Infection patients from the Emergency Department/Unit: place in therapy of dalbavancin19
Diagnostic and clinical management of Candida auris infections in immunocompromised patients18
Predicting the limit to ceftriaxone’s use in gonorrhea treatment: impending resistance and logistical challenges17
Prevention of viral infections in solid organ transplant recipients in the era of COVID-19: a narrative review17
Infliximab as a potential treatment for COVID-1917
Diagnostic and management strategies for chronic hepatitis E infection17
Clinical efficacy of nirmatrelvir plus ritonavir in patients with COVID-19 and preexisting cardiovascular diseases16
Analysis of bacterial spectrum and construction of a predictive model for postoperative sepsis in patients with upper urinary calculi and positive urinary cultures16
Healthcare professionals’ understanding and perception of drug-related issues linked to off-label pharmacological medications used for COVID-1916
Anti-inflammatory and immunomodulatory effects of mesenchymal stem cell therapy on parasitic drug resistance16
Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and pre–existing chronic obstructive pulmonary diseases16
Understanding host responses to equine encephalitis virus infection: implications for therapeutic development16
How SARS-CoV-2 dodges immune surveillance and facilitates infection: an analytical review15
In vitro and in vivo activity of meropenem+avibactam against MBL-producing carbapenem-resistant Klebsiella pneumoniae15
Correction15
Nintedanib: a review of the properties, function, and usefulness to minimize COVID-19-induced lung injury15
Challenges, risks, and opportunities of antiretroviral drugs in women of reproductive potential15
Statement of Retraction14
Diagnosing fungal infections in clinical practice: a narrative review14
Predictors and patterns of empirical antibiotic therapy and associated outcomes in COVID-19 patients: a retrospective study in a tertiary care facility in South India14
The serological dilemma: rethinking syphilis treatment evaluation14
The opportunities and challenges of epigenetic approaches to manage herpes simplex infections14
New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae14
Intravenous fosfomycin for the treatment of patients with bone and joint infections: a review13
Selling antibiotics without prescriptions among community pharmacies and drug outlets: a simulated client study from Ghana13
Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection13
Low-risk penicillin allergy delabeling: a scoping review of direct oral challenge practice, implementation, and multi-disciplinary approaches13
Perceptions and preparedness of senior medical students about antimicrobial stewardship programs: are we providing adequate training to future prescribers?13
Clinical utility of procalcitonin in implementation of procalcitonin-guided antibiotic stewardship in the South-East Asia and India: evidence and consensus-based recommendations13
Ceftazidime-avibactam and aztreonam combination for Carbapenem-resistant Enterobacterales bloodstream infections with presumed Metallo-β-lactamase production: a systemat13
Oteseconazole: a long-awaited diversification of the antifungal arsenal to manage recurrent vulvovaginal candidiasis (RVVC)13
Interrupting HIV transmission networks: how can we design and implement timely and effective interventions?12
Interaction of zincite, alpha-terpineol, geranyl acetate, linalool, myrcenol, terpinolene, and thymol with virulence factors of Escherichia coli, Mycobacterium tuberculosis, Pseudomonas12
Monotherapy versus combination for the treatment of Stenotrophomonas maltophilia: a multicenter cohort study12
Detection of SARS-CoV-2 by antigen ELISA test is highly swayed by viral load and sample storage condition12
An overview of potential combination therapies with ceftriaxone as a treatment for gonorrhoea12
Monoclonal antibodies for the treatment of COVID-19 infection in children12
Exploring thresholds and interaction effects among antibiotic usage, covariates, and their effect on antibiotic resistance using an extended-spectrum β-Lactamase–producing Klebsiella pneumoniae12
Prevalence and determinants of self-medication with antibiotics among general population in Afghanistan12
The evolving scenario of HCV-related mixed cryoglobulinemia and B-cell lymphoma in the era of direct-acting antivirals11
Real-world discontinuations due to neuropsychiatric symptoms in people living with HIV treated with second-generation integrase inhibitors: a systematic review11
The rise of mucormycosis in Covid-19 patients in India11
How can we tackle the overuse of antibiotics in low- and middle-income countries?11
Investigating forthcoming strategies to tackle deadly superbugs: current status and future vision11
Comparison of effectiveness and safety of nirmatrelvir/ritonavir versus sotrovimab for COVID-19: a systematic review and meta-analysis10
Evaluation of Namibia’s antiretroviral therapy guidelines’ recommendations for switching from first-line to second-line, using predictors of first-line treatment failure: an exploratory study10
Vitamin D attenuates biofilm-associated infections via immunomodulation and cathelicidin expression: a narrative review10
Gram-positive infections in special populations. Expert view on the role of dalbavancin10
Now that griseofulvin is not available, what to do with tinea capitis treatments?10
Tocilizumab for the treatment of COVID-1910
Practices, Knowledge, and Attitudes of Nephrologists Towards Prescribing and Monitoring Vancomycin at Dialysis Centers10
How do we best manage Clostridioides difficle infections in the elderly?10
Clinical outcomes, virological efficacy and safety of nitazoxanide in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials10
Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents9
Update on actinomycetoma treatment: linezolid in the treatment of actinomycetomas due to Nocardia spp and Actinomadura madurae resistant t9
Artificial intelligence and prescription of antibiotic therapy: present and future9
New insights into the treatment of acute otitis media9
Real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients9
Comparison of clinical outcomes of antibiotics used for Staphylococcus aureus bacteremia in pediatric patients9
Clinical efficacy and safety of ceftobiprole in the treatment of acute bacterial skin and skin structure infection: a systematic review and meta-analysis of randomized controlled trials9
Phage therapy: resurrecting a historical solution for the contemporary challenge of rising antibiotic resistance in Latin America9
Could Herpesviridae be the cause of severe acute hepatitis of unknown origin in children?9
Clinical efficacy of probiotics in the treatment of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials9
Nirmatrelvir and ritonavir combination: an antiviral therapy for COVID-198
Clinical outcomes of sofosbuvir-based antivirals in patients with COVID-19: a systematic review and meta-analysis of randomized trials8
Public knowledge of antibiotics, self-medication, and household disposal practices in Jordan8
An update on newer antifungals8
Effect of tixagevimab/cilgavimab for pre-exposure prophylaxis during the China Omicron outbreak8
Lenacapavir: a twice-yearly treatment for adults with multidrug-resistant HIV infection and limited treatment options8
Past, present, and future perspectives on aztreonam and avibactam8
Synergistic effect of eravacycline combined with fluconazole against resistant Candida albicans in vitro and in vivo8
Proposed amendments regarding the definitions of multidrug-resistant and extensively drug-resistant bacteria8
Ivermectin: a pathway out of the pandemic or another dead end?8
Global importance of new treatment strategies to efforts to control hepatitis B virus8
RETRACTED ARTICLE: Ivermectin role in COVID-19 treatment (IRICT): single-center, adaptive, randomized, double-blind, placebo-controlled, clinical trial8
Host defense mechanisms against Candida auris8
Assessing sex differential in COVID-19 mortality rate by age and polymerase chain reaction test results: an Iranian multi-center study8
Strengths and caveats of identifying resistance genes from whole genome sequencing data8
Understanding mechanisms of virulence in MRSA: implications for antivirulence treatment strategies8
Systematic Review and Meta-Analysis: Efficacy of Vancomycin Taper and Pulse Regimens in Clostridioides difficile Infection8
Diagnosis, prevention, and treatment of coronavirus disease: a review8
Metallo-beta-lactamases: mechanisms, treatment challenges, and future prospects8
An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of infection-related ventilator associated complications (IVACs) caused by Enterobacterales in critical8
Efficacy and safety of eravacycline (ERV) in treating infections caused by Gram-negative pathogens: a systematic review and meta-analysis8
0.18726420402527